Stocks Health care MRK
NYSE · Health careMerck & Co., Inc. (MRK)
Merck & Co., Inc. brought in $66.6B of revenue over the twelve months to June 30, 2026, up 4.6% from a year earlier. Net income was $3.2B, a net margin of 4.8%. Operating cash flow minus capital spending left $12.4B of free cash flow in fiscal 2025. At June 30, 2026 it held $6.8B in cash against $51.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Merck & Co., Inc. does
Merck & Co. develops and manufactures prescription medicines, vaccines, and animal health products. The company sells its drugs to hospitals, pharmacies, and healthcare providers worldwide. It is known for producing cancer therapies, diabetes treatments, and vaccines for human and animal use. Its shares trade on NYSE under the ticker MRK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $65B | $18.3B | $7.28 | $12.4B |
| 2024 | $64.2B | $17.1B | $6.74 | $18.1B |
| 2023 | $60.1B | $365M | $0.14 | $9.1B |
| 2022 | $59.3B | $14.5B | $5.71 | $14.7B |
| 2021 | $48.7B | $13B | $5.14 | $8.7B |
| 2020 | $41.5B | $7.1B | $2.78 | $5.8B |
Latest SEC filings
What Merck & Co., Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 7, 2026Form 13F-HR filing 13F-HR
- August 4, 2026
- June 24, 2026
- June 24, 2026
- June 24, 2026
- May 29, 2026
- May 28, 2026
- May 22, 2026Other event 8-K
- May 20, 2026
Questions about MRK
What does Merck & Co., Inc. do?
Merck & Co. develops and manufactures prescription medicines, vaccines, and animal health products. The company sells its drugs to hospitals, pharmacies, and healthcare providers worldwide. It is known for producing cancer therapies, diabetes treatments, and vaccines for human and animal use. Its shares trade on NYSE under the ticker MRK.
Is Merck & Co., Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $3.2B on revenue of $66.6B, a net margin of 4.8%.
How much revenue does Merck & Co., Inc. make?
Over the twelve months to June 30, 2026 Merck & Co., Inc. reported revenue of $66.6B. That is 4.6% more than a year earlier.
When did Merck & Co., Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the new insider holdings from September 1, 2026.
Similar companies
Follow MRK
Get an email when Merck & Co., Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MRK: get an email when it filesWhere the numbers come from
Financial figures are the values Merck & Co., Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.